• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性黑色素瘤的遗传学

The genetics of malignant melanoma.

作者信息

Lomas Jesus, Martin-Duque Pilar, Pons Mar, Quintanilla Miguel

机构信息

Instituto de Investigaciones Biomedicas Alberto Sols, Consejo Superior de Investigaciones Cientificas-Universidad Autonoma de Madrid, Spain.

出版信息

Front Biosci. 2008 May 1;13:5071-93. doi: 10.2741/3065.

DOI:10.2741/3065
PMID:18508571
Abstract

Melanoma probably is the most aggressive cancer in humans and remains one of the leading causes of cancer death in developed countries. This review summarizes the most important alterations in protooncogenes and tumor suppressor genes that contribute to the pathogenesis of malignant melanoma, with a special emphasis on the involved signaling pathways. Our knowledge of the molecular biology of melanoma has been benefited from recent advances on high-throughput technologies analyzing wide genomic and gene expression profiles that have uncovered unknown candidate genes. To test the interactions between distinct pathways and of those with the environment a wealth of genetically modified animal models has been generated over the past years. Other studies have focused on the isolation of melanoma stem cells and on the characterization of signaling pathways that contribute to their survival and maintenance. A consequence of all these studies is the emergence of potential new strategies that could improve the still inadequate arsenal of therapeutic tools to fight against this fatal disease.

摘要

黑色素瘤可能是人类最具侵袭性的癌症,并且仍然是发达国家癌症死亡的主要原因之一。本综述总结了原癌基因和肿瘤抑制基因中导致恶性黑色素瘤发病机制的最重要改变,特别强调了相关的信号通路。我们对黑色素瘤分子生物学的认识受益于高通量技术的最新进展,这些技术分析了广泛的基因组和基因表达谱,发现了未知的候选基因。为了测试不同信号通路之间以及这些信号通路与环境之间的相互作用,在过去几年中已经建立了大量的基因修饰动物模型。其他研究则集中在黑色素瘤干细胞的分离以及对有助于其存活和维持的信号通路的表征。所有这些研究的一个结果是出现了潜在的新策略,这些策略可以改进对抗这种致命疾病的治疗工具仍然不足的状况。

相似文献

1
The genetics of malignant melanoma.恶性黑色素瘤的遗传学
Front Biosci. 2008 May 1;13:5071-93. doi: 10.2741/3065.
2
Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma.细胞外信号调节激酶丝裂原活化蛋白激酶信号缺失显示出一种新型黑色素瘤。
Cancer Res. 2007 Feb 15;67(4):1502-12. doi: 10.1158/0008-5472.CAN-06-3311.
3
MicroRNAs in the pathogenesis of malignant melanoma.微小 RNA 在恶性黑色素瘤发病机制中的作用。
J Eur Acad Dermatol Venereol. 2013 Feb;27(2):142-50. doi: 10.1111/j.1468-3083.2012.04579.x. Epub 2012 May 23.
4
Recent patents on melanoma with focus on genetic strategies.近期关于黑色素瘤的专利,重点关注基因策略。
Recent Pat Antiinfect Drug Discov. 2008 Jun;3(2):136-44. doi: 10.2174/157489108784746632.
5
Recent discoveries in the genetics of melanoma and their therapeutic implications.黑色素瘤遗传学的最新发现及其治疗意义。
Arch Immunol Ther Exp (Warsz). 2007 Nov-Dec;55(6):363-72. doi: 10.1007/s00005-007-0043-5. Epub 2007 Dec 3.
6
Advances in malignant melanoma: genetic insights from mouse and man.恶性黑色素瘤的进展:来自小鼠和人类的遗传学见解
Front Biosci. 2006 Jan 1;11:928-42. doi: 10.2741/1849.
7
Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines.自发和致癌物诱导的小鼠黑色素瘤细胞系中的基因组改变。
Oncogene. 2004 Mar 25;23(13):2347-56. doi: 10.1038/sj.onc.1207405.
8
Molecular biology of malignant melanoma.
Adv Exp Med Biol. 2008;624:252-64. doi: 10.1007/978-0-387-77574-6_20.
9
Ras, Raf, and MAP kinase in melanoma.Ras、Raf 和 MAP 激酶在黑色素瘤中的作用。
Adv Anat Pathol. 2013 Jul;20(4):217-26. doi: 10.1097/PAP.0b013e3182976c94.
10
The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.BRAF(V600E)抑制剂PLX4032可增加黑色素瘤细胞中I型胶原蛋白的合成。
Matrix Biol. 2015 Oct;48:66-77. doi: 10.1016/j.matbio.2015.05.007. Epub 2015 May 16.

引用本文的文献

1
Tetrahydroanthraquinone Derivative (±)-4-Deoxyaustrocortilutein Induces Cell Cycle Arrest and Apoptosis in Melanoma Cells via Upregulation of p21 and p53 and Downregulation of NF-kappaB.四氢蒽醌衍生物(±)-4-脱氧澳柯替菌素通过上调p21和p53以及下调核因子κB诱导黑色素瘤细胞的细胞周期阻滞和凋亡。
J Cancer. 2016 Mar 12;7(5):555-68. doi: 10.7150/jca.13614. eCollection 2016.
2
Stage-specific prognostic biomarkers in melanoma.黑色素瘤的阶段特异性预后生物标志物。
Oncotarget. 2015 Feb 28;6(6):4180-9. doi: 10.18632/oncotarget.2907.
3
Insulin-like-growth-factor-binding-protein-3 (IGFBP-3) contrasts melanoma progression in vitro and in vivo.
胰岛素样生长因子结合蛋白-3(IGFBP-3)在体外和体内均能抑制黑色素瘤的进展。
PLoS One. 2014 Jun 6;9(6):e98641. doi: 10.1371/journal.pone.0098641. eCollection 2014.
4
Mechanism of RAF isoform switching induced by oncogenic RAS in melanoma.黑色素瘤中致癌性RAS诱导RAF亚型转换的机制。
Small GTPases. 2011 Sep;2(5):289-292. doi: 10.4161/sgtp.2.5.17814. Epub 2011 Sep 1.
5
New Perspectives of "omics" Applications in Melanoma Research.“组学”技术在黑色素瘤研究中的新应用前景
Open Biochem J. 2011;5:60-6. doi: 10.2174/1874091X01105010060. Epub 2011 Dec 30.
6
Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation.克服慢性炎症诱导的黑色素瘤微环境中的免疫抑制。
Cancer Immunol Immunother. 2012 Feb;61(2):275-282. doi: 10.1007/s00262-011-1164-6. Epub 2011 Nov 27.
7
TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome.TYRP1 mRNA 在黑色素瘤转移中的表达与临床结局相关。
Br J Cancer. 2011 Nov 22;105(11):1726-32. doi: 10.1038/bjc.2011.451. Epub 2011 Nov 1.
8
Circulating serologic and molecular biomarkers in malignant melanoma.循环血清学和分子生物标志物在恶性黑色素瘤中的研究进展。
Mayo Clin Proc. 2011 Oct;86(10):981-90. doi: 10.4065/mcp.2011.0287.
9
Biomarkers in melanoma.黑色素瘤中的生物标志物。
Ann Oncol. 2009 Aug;20 Suppl 6(Suppl 6):vi8-13. doi: 10.1093/annonc/mdp251.